Human Hemoglobin

Updated: 2026-09-11

Overview

Human Hemoglobin is a globular protein comprising four polypeptide chains (two α and two β subunits), each bound to a heme group containing iron. It constitutes 96% of red blood cells' dry content and is responsible for oxygen transport from lungs to tissues, with secondary roles in CO2 transport and pH buffering. In industrial contexts, hemoglobin is extracted from donated human blood or produced recombinantly for use in biomedical research, diagnostic kits, and experimental oxygen therapeutics. Its unique oxygen-binding kinetics make it irreplaceable for physiological studies and clinical applications.

Physical and Chemical Properties

Hemoglobin exhibits cooperative oxygen binding due to conformational changes between tense (T) and relaxed (R) states, with a P50 of ~26 mmHg in adults. The iron in heme cycles between Fe²⁺ (functional) and Fe³⁺ (non-functional methemoglobin) states, requiring enzymatic reduction systems in vivo. Its isoelectric point ranges from 6.8-7.4 depending on isoforms. The protein is sensitive to oxidation, pH changes (Bohr effect), and allosteric modifiers like 2,3-BPG. Ultracentrifugation reveals a sedimentation coefficient of 4.5S, while electrophoresis shows distinct bands for HbA, HbA2, and HbF variants.

Main Applications

Pharmaceutical-grade hemoglobin is processed into hemoglobin-based oxygen carriers (HBOCs) for trauma medicine, though none are currently FDA-approved due to vasoactivity concerns. Research applications include studying sickle cell disease (HbS), thalassemias, and developing artificial blood substitutes. In diagnostics, hemoglobin variants are analyzed via HPLC or electrophoresis for genetic disorder screening. Industrial uses encompass cell culture media supplements and biosensor development. Emerging applications explore hemoglobin nanoparticles for drug delivery and its peroxidase-like activity in biocatalysis.

Safety and Storage

Lyophilized hemoglobin is stable for years at -20°C but reconstituted solutions degrade within weeks even at 4°C. Avoid freeze-thaw cycles and store under inert gas to prevent oxidation to methemoglobin. Always use endotoxin-free vials for cell culture applications. Safety protocols mandate biosafety level 2 (BSL-2) handling for human-derived material due to potential bloodborne pathogens. Use nitrile gloves and respiratory protection when handling powder to prevent sensitization. Spills require enzymatic cleaners with protease activity for complete decontamination.

B2B Procurement Guide

Key specifications include: ≥95% purity (verified by SEC-HPLC), <0.1 EU/mg endotoxin, and ≤5% methemoglobin content. Recombinant E. coli-derived hemoglobin avoids human pathogen risks but lacks post-translational modifications. For clinical trials, ensure compliance with cGMP and ICH Q7 guidelines. Bulk buyers should request certificates of analysis (CoA) for electrophoresis patterns, osmolality (280-310 mOsm/kg), and sterility testing. Consider supplier accreditation (e.g., AABB for human-sourced material) and batch-to-batch consistency guarantees. Lead times for specialty isoforms (e.g., HbF) may exceed 12 weeks.